Treatment Outcomes of Patients With Multidrug Resistant / Rifampicin Resistant Tuberculosis Under the Nationwide Approval Process for Bedaquiline or Delamanid Use - KIVIRID

Treatment Outcomes of Patients With Multidrug Resistant / Rifampicin Resistant Tuberculosis Under the Nationwide Approval Process for Bedaquiline or Delamanid Use

Authors: H. Hwang, H. Kang, Y.S. Kwon, D. Jeon, T.S. Shim, J.-J. Yim

Published: 2025-05-11

DOI: 10.1164/ajrccm.2025.211.abstracts.a6578

Source: Full article

Abstract

No abstract found.